Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Lotus Eye Hospital And Institute Ltd - 532998 - Board to consider Final Dividend

 Lotus Eye Hospital And Institute Ltd has informed BSE that the Board of Directors of the Company will be meeting on May 25, 2022, inter alia, to consider the following:1. Audited Standalone Financial Results of the company for the quarter and year ended March 31, 2022.2. Consideration and proposed recommendation of Final DividendFurther, with reference to Company''s earlier intimation March 31, 2022, in accordance with SEBI (Prohibition of Insider Trading) Regulations. 2015 and the Code of Conduct for Insiders of the Company, the trading window will re-open from May 30, 2022 onwards.
16-05-2022
Bigul

Lotus Eye Hospital And Institute Ltd - 532998 - Board Meeting Intimation for Intimation Of Board Meeting

 Lotus Eye Hospital And Institute Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2022 ,inter alia, to consider and approve 1. Audited Standalone Financial Results of the company for the quarter and year ended March 31, 2022. 2. Consideration and proposed recommendation of Final Dividend
16-05-2022
Bigul

Lotus Eye Hospital And Institute Ltd - 532998 - Non Applicability Of Annual Disclosure Under Fund Raising By Issuance Of Debt Securities By Large Entities

 We hereby declare that Lotus Eye Hospital and Institute Limited is not a Large Corporate as defined in para 2.2 of the SEBI Circular dated 26th November 2018 as on the last day of the previous financial year 2021-22. Accordingly, Annual Disclsoure as mentioned in Annexure B2 of the said circular for the Annual Financial year 2021-22 is not applicable to the company
30-04-2022
Bigul

Lotus Eye Hospital And Institute Ltd - 532998 - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2

 Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company Lotus Eye Hospital And Institute Ltd 2 CIN NO. L85110TZ1997PLC007783 3 Report filed for FY 2021-2022 Details of the Current block (all figures in Rs crore): 4 2 - year block period (Specify financial years)* NA 5 Incremental borrowing done in FY (T)(a) 0.00 6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00 7 Actual borrowing done through debt securities in FY (T)(c) 0.00 8 Shortfall in the borrowing through debt securities, if any, for FY (T - 1) carried forward to FY (T) (d) 0 8Quantum of (d), which has been met from (c)(e)* 0 9 Shortfall, if any, in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative, write 'nil'}* 0 Details of penalty to be paid, if any, in respect to previous block (all figures in Rs crore): 2 - year Block period (Specify financial years)0 Amount of fine to be paid for the block, if applicable Fine = 0.2% of {(d) - (e)}#0.00 Name of the Company Secretary :-M Achuth menonDesignation :-Company Secretary Name of the Chief Financial Officer :- A Ganesh Designation : -CFO Date: 30/04/2022
30-04-2022
Bigul

Lotus Eye Hospital And Institute Ltd - 532998 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

 Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayLotus Eye Hospital And Institute Ltd 2CINL85110TZ1997PLC007783 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: M Achuth menon Designation: Company Secretary EmailId: [email protected] Name of the Chief Financial Officer: A Ganesh Designation: CFO EmailId: [email protected] Date: 30/04/2022 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
30-04-2022
Bigul

Lotus Eye Hospital And Institute Ltd - 532998 - Certificate Issued By A Practicing Company Secretary Under Regulation 40(9) Of SEBI (LODR) Regulations, 2015

 We are enclosing herewith certificate issued by a practicing Company Secretary under Regulation 40(9) of SEBI (LODR) Regulations, 2015. Request you to take the same on record. Thanking You Your Faithfully For Lotus Eye Hospital and Institute Limited M Achuth Menon Company Secretary & Compliance Officer Membership No- A63980
27-04-2022
Bigul

Lotus Eye Hospital And Institute Ltd - 532998 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for S Rajkumar
18-04-2022
Bigul

Lotus Eye Hospital And Institute Ltd - 532998 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

 The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on April 16, 2022 for S Rajkumar
18-04-2022
Bigul

Lotus Eye Hospital And Institute Ltd - 532998 - Statement Of Investor Complaints For The Quarter Ended March 2022

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- M Achuth MenonDesignation :- Company Secretary and Compliance Officer
09-04-2022
Bigul

Lotus Eye Hospital And Institute Ltd - 532998 - Compliance Certificate Pursuant To Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

 Pursuant to Regulation 7(3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed herewith Compliance Certificate duly signed by both the Company Secretary of Lotus Eye Hospital and Institute Limited and the Authorised Representative of the Share Transfer Agent for the financial year ended 31.03.2022.
06-04-2022
Next Page
Close

Let's Open Free Demat Account